Stay updated on JTX 8064 in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the JTX 8064 in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JTX 8064 in Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The NIH website-transition notice was removed from the page; the study record still displays a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-11-10T06:45:25.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0 on a page displaying a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T03:15:06.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website transition updates and says that some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).
    Difference
    1%
    Check dated 2026-10-27T06:28:14.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.1 to v3.7.2 while the study record page continued to show an error state.
    Difference
    0.2%
    Check dated 2026-10-20T06:29:01.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.0 to v3.7.1, while the study-record page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T08:08:21.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page, replacing the study content and menu with an error screen.
    Difference
    21%
    Check dated 2026-09-22T06:23:52.000Z thumbnail image

Stay in the know with updates to JTX 8064 in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JTX 8064 in Solid Tumors Clinical Trial page.